Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies
Pharmaceuticals · 02.03.2023 · 16 (3) · 382
DOI: 10.3390/ph16030382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 02.03.2023. Verfasst von Karam Chamoun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, UMR-S1144, Paris Cité University, 75006 Paris, France. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In 2020, fentanyl and its analogs contributed to ~65% of drug-attributed fatalities in the USA, with a threatening increasing trend during the last ten years. These synthetic opioids used as potent analgesics in human and veterinary medicine have been diverted to recreational aims, illegally produced and sold. Like all opioids, central nervous system depression resulting from overdose or misuse of fentanyl analogs is characterized clinically by the onset of consciousness impairment, pinpoint miosis and bradypnea. However, contrasting with what observed with most opioids, thoracic rigidity may occur rapidly with fentanyl analogs, contributing to increasing the risk of death in the absence of immediate life support. Various mechanisms have been proposed to explain this particularity associated with fentanyl analogs, including the activation of noradrenergic and glutamatergic coerulospinal neurons and dopaminergic basal ganglia neurons. Due to the high affinities to the mu-opioid receptor, the need for more elevated naloxone doses than usually required in morphine overdose to reverse the neurorespiratory depression induced by fentanyl analogs has been questioned. This review on the neurorespiratory toxicity of fentanyl and analogs highlights the need for specific research focused on these agents to better understand the involved mechanisms of toxicity and develop dedicated strategies to limit the resulting fatalities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inserm, UMR-S1144, Paris Cité University, 75006 Paris, France.
- Faculty of Pharmacy, Saint-Joseph University, Beirut 1100, Lebanon.
- Laboratory of Pharmacology, Clinical Pharmacy, and Medicine Quality Control, Saint-Joseph University, Beirut 1100, Lebanon.
- Research Center, Quebec University Hospital, Laval University, Québec, QC G1V 0A6, Canada.
- Laboratory of Biochemistry and Molecular Biology, AP-HP, Lariboisière Hospital, 75010 Paris, France.
- Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, 75010 Paris, France.
ORCID-Profile: Karam Chamoun, Lucie Chevillard, Jacques Callebert, Bruno Mégarbane
Zitieren
APA
Chamoun, K., Chevillard, L., Hajj, A., Callebert, J., & Mégarbane, B. (2023). Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies. Pharmaceuticals, 16(3), 382. https://doi.org/10.3390/ph16030382
Vancouver
Chamoun K, Chevillard L, Hajj A, Callebert J, Mégarbane B. Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies. Pharmaceuticals. 2023;16(3):382. doi:10.3390/ph16030382
BibTeX
@article{Chamoun2023,
author = {Chamoun, Karam and Chevillard, Lucie and Hajj, Aline and Callebert, Jacques and Mégarbane, Bruno},
title = {Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {3},
pages = {382},
doi = {10.3390/ph16030382}
}
EUVIMED